111 related articles for article (PubMed ID: 3002668)
41. In-vitro studies of normal human thyroid cells: responses to thyrotrophin and dibutyryl cyclic AMP.
Bidey SP; Marsden P; Anderson J; McKerron CG; Berry H
J Endocrinol; 1977 Jan; 72(1):87-96. PubMed ID: 188967
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the response of mouse thyroid to tryrotropin induced by chronic triiodothyronine treatment.
Gafni M; Sirkis N; Gross J
Endocrinology; 1975 Nov; 97(5):1256-62. PubMed ID: 171149
[TBL] [Abstract][Full Text] [Related]
43. Chronic effect of TSH on human thyroid tissue in organ culture.
Hamada N; Okabe T; Kubota K; Chiu SC; Uchimura H; Mimura T; Ito K; Nagataki S
Proc Soc Exp Biol Med; 1983 Feb; 172(2):153-7. PubMed ID: 6298795
[TBL] [Abstract][Full Text] [Related]
44. Sensitization and desensitization of human thyroid cells in culture: effects of thyrotrophin and thyroid-stimulating immunoglobulin.
Kraiem Z; Alkobi R; Sadeh O
J Endocrinol; 1988 Nov; 119(2):341-9. PubMed ID: 2462004
[TBL] [Abstract][Full Text] [Related]
45. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
46. Human thyroid cells in monolayer retain the ability to secrete tri-iodothyronine in response to thyrotrophin.
Ollis CA; Fowles A; Brown BL; Munro DS; Tomlinson S
J Endocrinol; 1985 Feb; 104(2):285-90. PubMed ID: 3968515
[TBL] [Abstract][Full Text] [Related]
47. Micromethod of human thyrocyte cultures for detection of thyroid-stimulating antibodies and thyrotrophin.
Stöckle G; Wahl R; Seif FJ
Acta Endocrinol (Copenh); 1981 Jul; 97(3):369-75. PubMed ID: 6266187
[TBL] [Abstract][Full Text] [Related]
48. Thyroid hormone receptors and 3,5,3'-triiodothyronine biological effects in FRTL5 thyroid follicular cells.
Akiguchi I; Strauss K; Borges M; Silva JE; Moses AC
Endocrinology; 1992 Sep; 131(3):1279-87. PubMed ID: 1324156
[TBL] [Abstract][Full Text] [Related]
49. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture.
Laburthe M; Rousset M; Boissard C; Chevalier G; Zweibaum A; Rosselin G
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2772-5. PubMed ID: 208077
[TBL] [Abstract][Full Text] [Related]
50. Paradoxically subnormal serum T4 and T3 in dogs after prolonged excessive TSH stimulation of the thyroid caused by post-cAMP refractoriness of thyroid hormone secretion.
Laurberg P
Metabolism; 1989 Mar; 38(3):265-70. PubMed ID: 2537453
[TBL] [Abstract][Full Text] [Related]
51. Evidence for alpha-adrenergic receptors acting through the guanylate cyclase system in human cultured thyroid cells.
Brandi ML; Rotella CM; Tanini A; Toccafondi RS
Acta Endocrinol (Copenh); 1983 Sep; 104(1):64-8. PubMed ID: 6137925
[TBL] [Abstract][Full Text] [Related]
52. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
Juarranz MG; Bodega G; Prieto JC; Guijarro LG
Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
[TBL] [Abstract][Full Text] [Related]
53. The mechanism of damping of the serum thyroxine and triidothyronine levels caused by increasing thyrotropin dosage in mice.
Gafni M; Saddok C; Sirkis N; Gross J
Endocrinology; 1977 Apr; 100(4):1186-91. PubMed ID: 189993
[TBL] [Abstract][Full Text] [Related]
54. Interferon-gamma inhibition of human thyrotropin receptor gene expression.
Nishikawa T; Yamashita S; Namba H; Usa T; Tominaga T; Kimura H; Izumi M; Nagataki S
J Clin Endocrinol Metab; 1993 Oct; 77(4):1084-9. PubMed ID: 8408457
[TBL] [Abstract][Full Text] [Related]
55. Requirement for cAMP-response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture.
Uyttersprot N; Costagliola S; Dumont JE; Miot F
Eur J Biochem; 1999 Jan; 259(1-2):370-8. PubMed ID: 9914516
[TBL] [Abstract][Full Text] [Related]
56. The inhibitory effect of noradrenaline on thyrotrophin-stimulated 3,5,3'-tri-iodothyronine and thyroxine release is mediated through a Ca(2+)-dependent process in the thyroid gland of the mouse.
Oda Y; Mashita K; Mori-Tanaka M; Kitajima K; Miyagawa J; Tajima K; Hanafusa T; Kono N; Matsuzawa Y
J Endocrinol; 1993 Jul; 138(1):73-80. PubMed ID: 7531751
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of thyrotrophin-stimulated cyclic AMP production in cultured human thyroid cells from thyrotoxic tissue and non-toxic goitres.
Ollis CA; Munro DS; Tomlinson S
J Endocrinol; 1982 Nov; 95(2):237-44. PubMed ID: 6294208
[TBL] [Abstract][Full Text] [Related]
58. Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis.
Suzuki H; Kadena N; Takeuchi K; Nakagawa S
Acta Endocrinol (Copenh); 1979 Nov; 92(3):477-88. PubMed ID: 517049
[TBL] [Abstract][Full Text] [Related]
59. Effects of vasoactive intestinal peptide on thyroid blood flow and circulating thyroid hormone levels in the rat.
Huffman L; Hedge GA
Endocrinology; 1986 Feb; 118(2):550-7. PubMed ID: 3943485
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory action of thyroid hormone of the activation of adenyl cyclase-cyclic AMP system by thyroid-stimulating hormone in human thyroid tissues from euthyroid subjects and thyrotoxic patients.
Takasu N; Sato S; Tsukui T; Yamada T; Furihata R
J Clin Endocrinol Metab; 1974 Oct; 39(4):772-8. PubMed ID: 4370110
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
